SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17043337
Source:
http://linkedlifedata.com/resource/pubmed/id/17043337
Search
Subject
(
60
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0003232
,
umls-concept:C0008976
,
umls-concept:C0022104
,
umls-concept:C0034656
,
umls-concept:C0073374
,
umls-concept:C0442027
,
umls-concept:C1280500
,
umls-concept:C1457887
pubmed:issue
8
pubmed:dateCreated
2006-10-17
pubmed:databankReference
http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00259155
pubmed:abstractText
Alterations in gut flora may be important in the pathophysiology of the irritable bowel syndrome (IBS).
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17043337-17043334
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17043337-17043344
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17043337-17224895
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0372351
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Infective Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Gastrointestinal Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Rifamycins
,
http://linkedlifedata.com/resource/pubmed/chemical/rifaximin
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1539-3704
pubmed:author
pubmed-author:KaneSunanda VSV
,
pubmed-author:KongYuthanaY
,
pubmed-author:MirochaJamesJ
,
pubmed-author:ParkSandyS
,
pubmed-author:PimentelMarkM
pubmed:issnType
Electronic
pubmed:day
17
pubmed:volume
145
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
557-63
pubmed:dateRevised
2007-10-4
pubmed:meshHeading
pubmed-meshheading:17043337-Adolescent
,
pubmed-meshheading:17043337-Adult
,
pubmed-meshheading:17043337-Aged
,
pubmed-meshheading:17043337-Anti-Infective Agents
,
pubmed-meshheading:17043337-Blind Loop Syndrome
,
pubmed-meshheading:17043337-Double-Blind Method
,
pubmed-meshheading:17043337-Female
,
pubmed-meshheading:17043337-Follow-Up Studies
,
pubmed-meshheading:17043337-Gastrointestinal Agents
,
pubmed-meshheading:17043337-Humans
,
pubmed-meshheading:17043337-Irritable Bowel Syndrome
,
pubmed-meshheading:17043337-Male
,
pubmed-meshheading:17043337-Middle Aged
,
pubmed-meshheading:17043337-Rifamycins
,
pubmed-meshheading:17043337-Treatment Outcome
pubmed:year
2006
pubmed:articleTitle
The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial.
pubmed:affiliation
Cedars-Sinai Medical Center, Burns and Allen Research Institute, and University of California, Los Angeles, Geffen School of Medicine, Los Angeles, California 90048, USA. pimentelm@cshs.org
pubmed:publicationType
Journal Article
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study